Last edition
News about Global Pharma
Lupin Secures USFDA Approval for Liraglutide and Glucagon Injectable Products
Global pharma giant Lupin has received approval from the US Food and Drug Administration (FDA) for its Abbreviated New Drug Applications (ANDAs) for Liraglutide Injection Single-Patient-Use Prefilled Pens and Glucagon for Injection vials.
Global Pharma | 24/07/2025 | By Dineshwori | 337
Torrent Pharma Enters Adult Nutrition Segment with Launch of Shelcal Total
Torrent Pharmaceuticals has announced the expansion of its flagship Shelcal brand into the growing nutrition segment with the launch of a scientifically formulated adult nutrition supplement powder.
Global Pharma | 24/07/2025 | By Dineshwori | 577
MHRA Unveils Major Regulatory Reforms to Accelerate Patient Access to Global Medical Technologies
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has announced sweeping reforms aimed at improving patient access to cutting-edge medical technologies and easing the regulatory burden on manufacturers.
Global Pharma | 24/07/2025 | By Darshana | 366
European Commission Approves DARZALEX Faspro for Adults with Smouldering Multiple Myeloma
Halozyme Therapeutics has announced European Commission approval for DARZALEX Faspro, co-formulated with ENHANZE, as a monotherapy for high-risk smouldering multiple myeloma in adults, marking a shift from passive monitoring to early intervention.
Global Pharma | 24/07/2025 | By Mrinmoy Dey | 199
India-UK FTA to Ease Regulatory Approvals, Boost Indian Pharma Exports: FIEO
Key Indian sectors such as textiles, apparel, leather, gems and jewellery, pharmaceuticals, marine and engineering goods are expected to gain substantially from the proposed India–UK Free Trade Agreement (FTA).
Global Pharma | 23/07/2025 | By Dineshwori | 216
Neuraxpharm Strengthens Global Footprint with Neuraxpharm Australia Launch
Neuraxpharm Group has launched Neuraxpharm Australia as part of its global expansion strategy, bringing key CNS treatments to the Australian market under the leadership of newly appointed Head of Commercial, Avendran Naidu.
Global Pharma | 23/07/2025 | By Mrinmoy Dey | 328
Samsung Biologics has announced its financial results for the second quarter of fiscal year 2025, posting strong growth across both consolidated and standalone metrics.
Global Pharma | 23/07/2025 | By Dineshwori | 1479
Nandani Medical Laboratories has entered into a strategic collaboration with Shanghai-based pharmaceutical machinery innovator Xin Weisheng to advance intelligent pharma quality in India.
Global Pharma | 23/07/2025 | By Dineshwori | 237
Johnson and Johnson to Co-Promote ZILRETTA with Pacira BioSciences
Johnson and Johnson MedTech and Pacira BioSciences have announced a strategic collaboration to expand the market reach of ZILRETTA - Pacira’s extended-release treatment for osteoarthritis knee pain.
Global Pharma | 22/07/2025 | By Dineshwori | 436
Biogen to Invest USD 2 Billion in USA Manufacturing Hub Amid Policy Shifts
The upcoming site will serve as a hub for biologics production, supporting Biogen’s pipeline of therapies for neurological and rare diseases. This strategic move not only enhances the company’s operational resilience but also strengthens its presence in the USA, one of its key markets.
Global Pharma | 22/07/2025 | By Darshana | 144
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy